VS

Vivek Sharma

Active Director Director DIN 09623216
DIN 09623216 First appointment May 2022 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Vivek Sharma

Data last updated:

Vivek Sharma is a Director at Snh Pharma Private Limited (since 2022). The company operates in Food And Beverages. Snh Pharma Private Limited reported revenue of ₹23.6 Lakh (FY 2024).

DIN 09623216
Primary Designation Director
Industry Food And Beverages
First Appointment 27 May 2022
Oldest Company Age 4 yrs
Largest company Snh Pharma Private Limited · ₹23.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Snh Pharma Private Limited U24304GJ2022PTC132470
Director27 May 20222022₹23.6 Lakh (FY 2024)Active

Board colleagues of Vivek Sharma

Directorship timeline

Open interactive timeline →
Snh Pharma Private Limited
Premium access

Shareholding and investment profile for Vivek Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Sharma

Vivek Sharma currently holds 1 directorship: Snh Pharma Private Limited (Director, since 27 May 2022, revenue ₹23.6 Lakh (FY 2024)).

Vivek Sharma was first appointed on 27 May 2022 as Director at Snh Pharma Private Limited.

The current boards of Vivek Sharma's companies include Pinky Riteshkumar Kansara (Snh Pharma Private Limited), Rutul Maulesh Shah (Snh Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available